Actinogen Medical
Sydney, New South Wales, Australia · Biotechnology, Health Care, Medical
Actinogen Medical is developing a novel therapy for neurological and neuropsychiatric diseases associated with dysregulated brain cortisol. It is currently developing its lead compound, Xanamem, as a potential new therapy for Alzheimer’s disease and depression.
Key facts
- Headquarters
- Sydney, New South Wales, Australia
- Employees
- 16
- Industries
- Biotechnology, Health Care, Medical
- Status
- Private
- Website
- actinogen.com.au
- Company page
Recent activity at Actinogen Medical
Leadership
- Steven Gourlay, Chief Executive Officer
- Andrew Udell, Chief Commercial Officer
- Will Souter, Chief Financial Officer
Verified email and direct lines for Actinogen Medical’s decision-makers are on Fundz. See plans
Actinogen Medical in the news
- Actinogen Medical completes final XanaMIA patient visit; November Alzheimer’s trial results on track - Yahoo Finance Australia (Sep 22, 2026)
- What could Actinogen Medical (ASX:ACW) mean for Healthcare Stocks? - Kalkine Media (Sep 23, 2026)
- Actinogen commences open-label phase of XanaMIA Alzheimer’s trial and provides business update - globenewswire.com (Apr 01, 2026)
- Can Actinogen Medical (ASX:ACW) Stay in Focus as the ASX Turns Risk-Off? - Kalkine Media (Sep 24, 2026)
- Targeting Brain Cortisol: Xanamem Shows Promise in Depression and Alzheimer Disease - Psychiatric Times (May 17, 2025)
- Small Caps Watch: XSO climbs as Critical Resources gains news ground and Actinogen nears Alzheimer’s readout - Yahoo Finance Australia (Sep 23, 2026)
- Actinogen Announces Phase 2 Trials in Alzheimer's Disease and Depression - globenewswire.com (Jun 14, 2022)
- New pill provides breakthrough in Alzheimer’s treatment - Herald Sun (Nov 16, 2024)
Companies similar to Actinogen Medical
- Diakonos Oncology · Biotechnology, Health Care, Medical, Therapeutics
- First Ascent Biomedical · Biotechnology, Health Care, Medical, Therapeutics
- Racura Oncology · Biotechnology, Health Care, Medical, Therapeutics
- VahatiCor · Biotechnology, Health Care, Medical, Therapeutics
- Medical Technology Enterprise Consortium (MTEC) · Biotechnology, Health Care, Medical, Therapeutics
About Actinogen Medical: questions and answers
What does Actinogen Medical do?
Actinogen Medical is developing a novel therapy for neurological and neuropsychiatric diseases associated with dysregulated brain cortisol. It is currently developing its lead compound, Xanamem, as a potential new therapy for Alzheimer’s disease and depression.
Where is Actinogen Medical headquartered?
Actinogen Medical is headquartered in Sydney, New South Wales, Australia.
How many employees does Actinogen Medical have?
Actinogen Medical has about 16 employees.
Who leads Actinogen Medical?
Steven Gourlay is a Chief Executive Officer at Actinogen Medical.
What is the latest news on Actinogen Medical?
On Oct 29, 2024, Actinogen Medical Appoints Andrew Udell as Chief Commercial Officer reporting to CEO Dr Steven Gourlay
Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy